Literature DB >> 29362834

[Postmenopausal lichen planopilaris also known as fibrosing frontotemporal alopecia Kossard : An evidence-oriented practical guide to treatment from the University of the Saarland, Hair Research Center of the Dr. Rolf M. Schwiete Foundation].

T Vogt1,2, C Thomas3,4, J Reichrath3,4, L Schilling3, D Mawlood3,4, R Christmann4,5,6, B Loretz5, U Schäfer6, C-M Lehr4,5,6, C Müller3,4.   

Abstract

Postmenopausal lichen planopilaris (PLPP), also known as fibrosing frontotemporal alopecia Kossard (FFAK), is a not uncommon inflammatory scalp disease affecting approximately 5% of patients at specialized hair centers. The overall incidence of sporadic occurrence is believed to be just under 1% in the older, predominantly female, general population. Since the disease is often undiagnosed, it is statistically likely to be underrepresented. It especially occurs in postmenopausal women who are in the 6th and 7th decade of life (90%), but also in about 10% of premenopausal women, and in men it is documented only in isolated cases. The result is a permanent scarring hair loss accentuated at the front hairline with backward movement towards the neck mostly accompanied by a typical loss of the eyebrows. The disease therefore often leads to significant mental distress and social anxiety in those affected. This is the basis for a compelling need to develop evidence-based therapeutic concepts. While numerous retrospective case series have characterized the phenomenology of FFAK very well, to date there are no randomized controlled trials on evidence-based therapy. Here, we present the Homburger Evidence-Oriented Therapy Algorithm, which is oriented along the available case series evidence: It may (1) serve as a therapy guide for practice and (2) can be used as a basis for working out reliable data based on study evidence. The article contains detailed practical information on photo documentation, biopsy and histological processing up to the practical implementation of, for example, intralesional steroid therapy as well as information on selection criteria for suitable systemic therapies.

Entities:  

Keywords:  Finasteride; Janus-kinase inhibitors; Kossard; Lichenoid folliculitis; Nanopaticle

Mesh:

Substances:

Year:  2018        PMID: 29362834     DOI: 10.1007/s00105-017-4118-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  40 in total

1.  A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata.

Authors:  Maya Deeb; Renée A Beach
Journal:  J Cutan Med Surg       Date:  2017-06-21       Impact factor: 2.092

2.  Aging of hair.

Authors:  Ralph M Trüeb
Journal:  J Cosmet Dermatol       Date:  2005-06       Impact factor: 2.696

Review 3.  Individualizing treatment and choice of medication in lichen planus: a step by step approach.

Authors:  Ioannis Manousaridis; Kleanthis Manousaridis; Wiebke Katharina Peitsch; Stefan Werner Schneider
Journal:  J Dtsch Dermatol Ges       Date:  2013-08-26       Impact factor: 5.584

4.  Lichenoid folliculitis: A unifying concept.

Authors:  Mamina M Turegano; Leonard C Sperling
Journal:  J Cutan Pathol       Date:  2017-05-05       Impact factor: 1.587

5.  Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.

Authors:  S Kossard; M S Lee; B Wilkinson
Journal:  J Am Acad Dermatol       Date:  1997-01       Impact factor: 11.527

6.  Frontal fibrosing alopecia: a survey in 16 patients.

Authors:  D Moreno-Ramírez; F Camacho Martínez
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-11       Impact factor: 6.166

7.  Use of pioglitazone in patients with lichen planopilaris.

Authors:  Akerke Baibergenova; Scott Walsh
Journal:  J Cutan Med Surg       Date:  2012 Mar-Apr       Impact factor: 2.092

8.  Frontal fibrosing alopecia: clinical presentations and prognosis.

Authors:  K T Tan; A G Messenger
Journal:  Br J Dermatol       Date:  2008-09-22       Impact factor: 9.302

9.  Frontal fibrosing alopecia presenting with components of Piccardi-Lassueur-Graham-Little syndrome.

Authors:  Ossama Abbas; Adele Chedraoui; Samer Ghosn
Journal:  J Am Acad Dermatol       Date:  2007-08       Impact factor: 11.527

10.  Clinical Efficacy and Safety of Methotrexate versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial.

Authors:  Farahnaz Fatemi Naeini; Mina Saber; Ali Asilian; Sayed Mohsen Hosseini
Journal:  Int J Prev Med       Date:  2017-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.